These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 18414397

  • 1. Discovery and biological characterization of a novel series of androgen receptor modulators.
    Zhou C, Wu G, Feng Y, Li Q, Su H, Mais DE, Zhu Y, Li N, Deng Y, Yang D, Wang MW.
    Br J Pharmacol; 2008 May; 154(2):440-50. PubMed ID: 18414397
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tanshinones from Chinese medicinal herb Danshen (Salvia miltiorrhiza Bunge) suppress prostate cancer growth and androgen receptor signaling.
    Zhang Y, Won SH, Jiang C, Lee HJ, Jeong SJ, Lee EO, Zhang J, Ye M, Kim SH, Lü J.
    Pharm Res; 2012 Jun; 29(6):1595-608. PubMed ID: 22281759
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Biological properties of androgen receptor pure antagonist for treatment of castration-resistant prostate cancer: optimization from lead compound to CH5137291.
    Kawata H, Arai S, Nakagawa T, Ishikura N, Nishimoto A, Yoshino H, Shiraishi T, Tachibana K, Nakamura R, Sato H.
    Prostate; 2011 Sep; 71(12):1344-56. PubMed ID: 21308717
    [Abstract] [Full Text] [Related]

  • 7. Effects of treatment with androgen receptor ligands on microRNA expression of prostate cancer cells.
    Segal CV, Koufaris C, Powell C, Gooderham NJ.
    Toxicology; 2015 Jul 03; 333():45-52. PubMed ID: 25846647
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and biological activity of a novel series of nonsteroidal, peripherally selective androgen receptor antagonists derived from 1,2-dihydropyridono[5,6-g]quinolines.
    Hamann LG, Higuchi RI, Zhi L, Edwards JP, Wang XN, Marschke KB, Kong JW, Farmer LJ, Jones TK.
    J Med Chem; 1998 Feb 12; 41(4):623-39. PubMed ID: 9484511
    [Abstract] [Full Text] [Related]

  • 9. Galectin-3 Is Implicated in Tumor Progression and Resistance to Anti-androgen Drug Through Regulation of Androgen Receptor Signaling in Prostate Cancer.
    Dondoo TO, Fukumori T, Daizumoto K, Fukawa T, Kohzuki M, Kowada M, Kusuhara Y, Mori H, Nakatsuji H, Takahashi M, Kanayama HO.
    Anticancer Res; 2017 Jan 12; 37(1):125-134. PubMed ID: 28011482
    [Abstract] [Full Text] [Related]

  • 10. Preclinical pharmacology of FL442, a novel nonsteroidal androgen receptor modulator.
    Poutiainen PK, Huhtala T, Jääskeläinen T, Petsalo A, Küblbeck J, Kaikkonen S, Palvimo JJ, Raunio H, Närvänen A, Peräkylä M, Juvonen RO, Honkakoski P, Laatikainen R, Pulkkinen JT.
    Mol Cell Endocrinol; 2014 Apr 25; 387(1-2):8-18. PubMed ID: 24565895
    [Abstract] [Full Text] [Related]

  • 11. 2-(2,2,2-Trifluoroethyl)-5,6-dichlorobenzimidazole derivatives as potent androgen receptor antagonists.
    Ng RA, Guan J, Alford VC, Lanter JC, Allan GF, Sbriscia T, Lundeen SG, Sui Z.
    Bioorg Med Chem Lett; 2007 Feb 15; 17(4):955-8. PubMed ID: 17134895
    [Abstract] [Full Text] [Related]

  • 12. Selective androgen receptor modulator activity of a steroidal antiandrogen TSAA-291 and its cofactor recruitment profile.
    Hikichi Y, Yamaoka M, Kusaka M, Hara T.
    Eur J Pharmacol; 2015 Oct 15; 765():322-31. PubMed ID: 26335395
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Targeted androgen pathway suppression in localized prostate cancer: a pilot study.
    Mostaghel EA, Nelson PS, Lange P, Lin DW, Taplin ME, Balk S, Ellis W, Kantoff P, Marck B, Tamae D, Matsumoto AM, True LD, Vessella R, Penning T, Hunter Merrill R, Gulati R, Montgomery B.
    J Clin Oncol; 2014 Jan 20; 32(3):229-37. PubMed ID: 24323034
    [Abstract] [Full Text] [Related]

  • 16. The development of Casodex (bicalutamide): preclinical studies.
    Furr BJ.
    Eur Urol; 1996 Jan 20; 29 Suppl 2():83-95. PubMed ID: 8717469
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and preliminary investigations into novel 1,2,3-triazole-derived androgen receptor antagonists inspired by bicalutamide.
    Altimari JM, Niranjan B, Risbridger GP, Schweiker SS, Lohning AE, Henderson LC.
    Bioorg Med Chem Lett; 2014 Nov 01; 24(21):4948-53. PubMed ID: 25301770
    [Abstract] [Full Text] [Related]

  • 18. The preclinical development of bicalutamide: pharmacodynamics and mechanism of action.
    Furr BJ, Tucker H.
    Urology; 1996 Jan 01; 47(1A Suppl):13-25; discussion 29-32. PubMed ID: 8560673
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Identification and optimization of a novel series of [2.2.1]-oxabicyclo imide-based androgen receptor antagonists.
    Salvati ME, Balog A, Shan W, Rampulla R, Giese S, Mitt T, Furch JA, Vite GD, Attar RM, Jure-Kunkel M, Geng J, Rizzo CA, Gottardis MM, Krystek SR, Gougoutas J, Galella MA, Obermeier M, Fura A, Chandrasena G.
    Bioorg Med Chem Lett; 2008 Mar 15; 18(6):1910-5. PubMed ID: 18291644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.